The Contract Manager will serve as an enterprise-wide contracting partner, drafting, reviewing, and negotiating a high volume of commercial and clinical agreements. They will also manage the end-to-end contract lifecycle and partner with cross-functional stakeholders to ensure compliance and operational efficiency.
The Associate Director is responsible for defining and executing market access strategies to ensure patient access to innovative oncology therapies in Germany. This includes leading value dossier submissions, managing pricing negotiations, and engaging with key external stakeholders and HTA bodies.
The Associate Director will oversee end-to-end distribution operations, managing relationships with 3PLs, specialty distributors, and specialty pharmacies. They will also collaborate with cross-functional teams to ensure operational excellence, compliance, and the successful commercialization of the company's oncology portfolio.
Lead project management support for global commercialization teams to drive alignment, accountability, and execution across strategic priorities. Coordinate inputs across various departments including medical, market access, and regulatory to ensure cohesive commercialization plans.
The Director will lead, coach, and develop a high-performing Medical Science Liaison team while driving field medical strategies in Germany. They are responsible for ensuring high-quality scientific engagement with medical experts and translating external insights into actionable medical strategies.
The Executive Director will lead global collaboration to develop and execute PDAC marketing strategies for lead RAS programs in preparation for product launches. They will partner with cross-functional teams to shape strategic plans, manage promotional tactics, and ensure alignment across clinical, medical, and commercial functions.
The Senior Director will establish global pricing architecture, governance processes, and financial models to support the launch of oncology therapies. They will partner with cross-functional teams to ensure compliant, value-based pricing execution and sustainable patient access across global markets.
The Commercial Lead for Switzerland is responsible for defining and executing the local commercial strategy, including product launches and portfolio growth. They will lead the country commercial organization, manage cross-functional alignment with Medical Affairs and Market Access, and oversee stakeholder engagement.
The Vice President of PDAC Marketing will lead the development and execution of strategic brand plans and launch trajectories for lead RAS programs. This role involves building and managing a marketing team, collaborating with cross-functional partners, and establishing strategic partnerships to drive product growth.
The Medical Science Liaison will execute field medical plans, engage in peer-to-peer scientific exchange with healthcare professionals, and gather medical insights within the Swiss territory. They will also support clinical study site engagement and collaborate cross-functionally to support medical strategies.
The Associate Director will develop and execute government affairs strategies in Germany to establish the company as a credible partner within the healthcare policy landscape. They will cultivate relationships with government entities and industry stakeholders while providing strategic counsel to leadership.
The Director of Market Access for BeLux is responsible for defining and executing country-level market access strategies to ensure patient access to innovative oncology therapies. This role involves leading reimbursement negotiations, developing value dossiers, and engaging with key external stakeholders including payers and HTA bodies.
The Tax Manager will oversee global tax compliance, reporting, and international tax matters, including VAT/GST and transfer pricing. They will also manage domestic tax provisions, SEC disclosures, and coordinate with internal and external teams on audits and tax filings.
The Medical Science Liaison will cultivate relationships with key opinion leaders and healthcare professionals to facilitate scientific exchange and provide medical expertise. They will also collaborate cross-functionally to support clinical development, medical strategy, and the dissemination of scientific data.
The Associate Director will lead national Medical Affairs activities in Germany, establishing scientific relationships with key opinion leaders and healthcare professionals. They will provide medical oversight for cross-functional teams and contribute to clinical research, market access strategies, and the development of medical materials.
The Associate Director will define and execute market access strategies to ensure patient access to innovative oncology therapies in Germany. This includes leading HTA filings, managing pricing negotiations, and engaging with key external stakeholders and health authorities.
The Manager of Revenue Accounting will oversee revenue and gross-to-net close activities, including reserves, journal entries, and account reconciliations. They will also partner with cross-functional teams to support forecasting models, audit requirements, and financial reporting deliverables.
The Executive Director will partner with the U.S. General Manager to drive operational excellence, scale organizational capabilities, and ensure cross-functional alignment across the U.S. commercial region. This role involves leading key business processes, managing governance structures, and fostering a unified culture to support the company's oncology portfolio.
The Senior Manager will develop and execute marketing plans for lead RAS(ON) programs to support clinical launches and in-line business. They will collaborate with cross-functional teams and external agencies to drive customer engagement and ensure strategic alignment with brand goals.
The Director will lead the strategy, design, and implementation of global named patient access initiatives for investigational therapies. They will manage cross-functional operations and ensure compliance with regulatory requirements while overseeing vendor partnerships.
The Director will serve as a strategic partner to the VP of US Market Access, driving operational excellence and cross-functional alignment across the organization. They are responsible for translating strategic objectives into actionable plans, managing key business initiatives, and ensuring successful product launches.
The Director will develop and lead strategic net pricing and contracting recommendations to optimize market position and financial outcomes. They will oversee provider contracting strategies and deliver executive-level pricing materials to inform senior leadership decision-making.
The Director, Global Insights will develop and execute a global insights roadmap to inform product strategy and portfolio decisions across the oncology pipeline. They will translate complex market research into actionable strategic recommendations for senior leadership and cross-functional stakeholders.
The Senior Director will lead the development and execution of patient-reported outcomes (PRO) strategies to support clinical development, regulatory submissions, and market access. They will collaborate with cross-functional teams to integrate patient-centered endpoints into study designs and ensure high-quality evidence generation throughout the product lifecycle.
The Senior Director will develop and execute US Medical Affairs strategies, focusing on launch readiness and life cycle management for gastrointestinal and oncology assets. They will serve as a therapeutic area expert, leading cross-functional teams and engaging with key external stakeholders to drive scientific strategy.
The Senior Manager, Patient Access Advocate will act as a single point of contact to manage patient cases, ensuring access to therapies by navigating insurance, benefits, and financial barriers. They will collaborate with healthcare providers, specialty pharmacies, and internal teams to resolve access issues and support the patient journey from enrollment to treatment.
The Nurse Case Manager will act as a single point of contact to manage patient access, insurance coverage, and financial barriers for oncology therapies. They will collaborate with healthcare providers, specialty pharmacies, and internal teams to ensure seamless patient support and resolve access bottlenecks.
The Senior Manager, Patient Access Advocate will act as a single point of contact to manage patient cases, ensuring access to therapies by navigating insurance policies, benefits verification, and appeals. They will collaborate with healthcare providers, specialty pharmacies, and internal teams to resolve access barriers and support patients throughout their treatment journey.
The preclinical study manager oversees operational activities for non-GLP and GLP toxicology studies, serving as the primary liaison between the company and contract research organizations. They ensure scientific objectives are met, manage study timelines, and facilitate regulatory compliance throughout the drug development process.
The Director will lead the development and execution of marketing strategies for pancreatic cancer programs, including launch readiness and in-line business support. They will collaborate with cross-functional teams and manage external agencies to drive brand performance and customer engagement.
The Director, Global Benefits will lead the evaluation, design, and strategic oversight of global benefits programs while building scalable governance and operational frameworks. They will partner with cross-functional teams to ensure competitive, sustainable, and compliant benefits that support a rapidly growing global workforce.
The Senior Director will develop and execute global medical affairs strategies, focusing on launch readiness and lifecycle management for GI oncology assets. They will lead cross-functional collaborations and engage with key opinion leaders to translate scientific insights into actionable medical tactics.
The Associate Director will oversee end-to-end distribution operations, managing relationships with 3PL providers, specialty distributors, and pharmacies to ensure commercial success. They will also collaborate with cross-functional teams to drive process improvements and ensure compliance with regulatory and legal requirements.
The Senior Oncology Account Manager is responsible for promoting Revolution Medicines' products and building strong relationships with key oncology stakeholders. They will act as a strategic partner to identify growth opportunities and ensure patient access to therapies while managing territory resources effectively.
The Senior QA Manager will lead internal and external GxP audits, manage supplier quality programs, and ensure compliance with regulatory standards. They will also negotiate quality agreements, monitor supplier performance metrics, and support preparation for regulatory inspections.
The Director of Marketing will lead the development and execution of strategic and promotional plans for RAS(ON) programs in preparation for lung cancer product launches. This role involves collaborating with cross-functional teams, managing agency relationships, and leveraging market insights to drive brand performance.
The Director of Medical Affairs for BeLux is responsible for defining and executing the local medical strategy and leading the medical team for the oncology portfolio. This role involves building strong relationships with key opinion leaders and ensuring scientific excellence while collaborating with cross-functional teams to support product launches and market access.
The Market Access Director is responsible for defining and executing the country market access strategy to ensure timely patient access to innovative oncology therapies in Poland. This role involves leading pricing negotiations, developing value dossiers, and engaging with key stakeholders including payers and HTA authorities.
The Director of Medical Affairs for Poland is responsible for defining and executing the local medical strategy for the oncology portfolio. This role involves leading scientific exchange, building relationships with key opinion leaders, and ensuring alignment between global strategy and local healthcare needs.
The Medical Science Liaison will engage in peer-to-peer scientific dialogue with healthcare professionals and serve as a key liaison between the company and clinical study sites. They will also provide scientific support for medical congresses, advisory boards, and internal teams to advance medical strategies.
The Senior Director will lead the development and execution of oncology-focused Corporate Affairs strategies in Italy, encompassing media relations, public affairs, and internal communications. This role involves building executive visibility, managing corporate reputation, and ensuring alignment with regional and global company objectives.
The Senior Director will lead global commercial strategy and marketing capabilities for oncology products, driving launch readiness and cross-functional collaboration. They will translate scientific insights into compelling brand strategies while managing external partnerships and supporting early-stage pipeline development.
The Senior Manager will lead the scaling of global inventory and cost accounting processes, including standard costing and ERP system development. They will also partner with cross-functional teams to manage inventory valuation, transfer pricing, and audit compliance.
The Vice President will develop and execute global commercialization partnership strategies while managing a network of distributors and regional alliances. They will lead a high-performing team to ensure operational excellence, launch readiness, and cross-functional alignment across global and regional stakeholders.
The Senior Oncology Account Manager is responsible for the direct promotion of oncology products and building strong professional relationships with key stakeholders in the Swiss oncology ecosystem. This role involves strategic account management, identifying growth opportunities, and collaborating cross-functionally to ensure patient access to targeted therapies.
The Medical Science Liaison will execute field medical plans, engage in peer-to-peer scientific exchange with healthcare professionals, and gather medical insights within the UK territory. They will also support clinical study site engagement and collaborate cross-functionally with internal teams to advance the company's oncology pipeline.
The Medical Advisor will lead pre-launch medical affairs strategy and establish scientific relationships with key opinion leaders across the UK. They will provide medical oversight to cross-functional teams and support clinical research activities to ensure scientific integrity and alignment with global objectives.
The Director will lead project management support for global commercialization teams, driving alignment and execution across strategic priorities. They will coordinate cross-functional inputs from medical, market access, and regulatory teams to ensure cohesive commercialization plans and launch readiness.
The MSL will execute field medical plans in France by engaging in scientific dialogue with healthcare professionals and cultivating relationships with Key Opinion Leaders. They will serve as a therapeutic expert and liaison between the company and clinical study sites to support medical education and congresses.
Lead the drafting and management of complex clinical regulatory documents such as protocols, CSRs, and NDA modules. Act as the primary medical writing contact for clinical development programs and mentor junior writers.
The role focuses on optimizing regional access to oncology pipeline products by building strategic relationships with payers and public affairs stakeholders in Spain. Key duties include implementing market access strategies, negotiating pricing and reimbursement, and presenting value evidence tools to regional health administrations.
This role focuses on improving the adoption of Digital and AI capabilities by creating a governed system for knowledge capture and training content management. It involves managing the AI Champion Network and translating technical outputs into reusable enterprise assets.
Lead and develop a team of Senior Oncology Account Managers to exceed performance targets in the North-Center area of Spain. Drive commercial success by implementing sales strategies and managing key relationships with healthcare accounts and regional stakeholders.
Lead the development of customer-centric HEOR and RWE strategies to optimize patient access for oncology products. Translate complex evidence to population-level decision makers and cultivate research partnerships with external stakeholders.
Lead the global commercial precision medicine and companion diagnostics strategy to ensure successful product launches and maximize patient access. Partner with cross-functional teams and external diagnostic partners to integrate biomarker strategies into therapeutic development and commercialization.
The MSL will engage in peer-to-peer scientific dialogue with healthcare professionals and KOLs to gather insights and advance medical knowledge. They will serve as a therapeutic expert and liaison between the company and clinical study sites, supporting medical congresses and advisory boards.
The Senior Oncology Account Manager is responsible for promoting oncology products and building professional relationships with healthcare providers and stakeholders in Germany. The role involves strategic territory management, implementing integrated initiatives to achieve sales goals, and collaborating cross-functionally to improve patient access to care.
Define and drive global value, access, and pricing strategies for oncology assets across their entire lifecycle. Influence clinical development and evidence generation to maximize long-term asset value and ensure sustainable patient access.
Develop and execute HEOR/RWE strategies to demonstrate the value of oncology products for pancreatic and colorectal cancers. Collaborate with cross-functional teams to optimize Integrated Evidence Plans and engage with external payers and HTA agencies.
Define and execute the market access strategy to ensure timely patient access to oncology therapies in Germany. Lead the preparation of AMNOG benefit assessments and negotiate pricing and reimbursement with statutory health insurance decision makers.
Lead and develop a team of 8 sales representatives to exceed performance targets for oncology products in the Great Lakes area. Manage strategic relationships with major health systems and GPOs while collaborating with cross-functional partners to drive product utilization.
Lead and develop a team of 8 sales representatives to exceed performance targets and promote oncology products in the Prairie area. Manage strategic relationships with major health systems and GPOs while collaborating with cross-functional partners to drive business growth.
Lead and develop a team of 8 sales representatives to exceed performance targets for oncology products in the Northeast region. Manage strategic relationships with major health systems and GPOs while collaborating with cross-functional partners to drive product utilization.
Lead and develop a team of 8 sales representatives to exceed performance targets in the Mid-Atlantic oncology market. Manage strategic relationships with major health systems and GPOs to maximize product utilization and brand reputation.
Lead and develop a team of 8 sales representatives to exceed performance targets for oncology products in the Upper South area. Manage strategic relationships with healthcare accounts and collaborate with cross-functional partners to drive product utilization.
Lead and develop a team of 8 sales representatives to exceed performance targets in the Gulf Coast oncology market. Manage strategic relationships with major health systems and GPOs to maximize product utilization and brand reputation.
Lead and develop a team of 8 sales representatives to exceed performance targets for oncology products in the West area. Manage key business relationships with healthcare accounts and execute strategic plans to maximize product utilization.
Lead regulatory activities and strategies for oncology programs in Japan, focusing on clinical development, registration, and lifecycle management. Act as the primary regulatory lead for PMDA interactions and represent Japan Regulatory Affairs on global project teams.
Lead the strategic design and execution of field enablement and analytics systems to drive commercial performance for US field teams. Coordinate communication and operational frameworks between field teams and home office functions to ensure seamless execution.
Lead the commercial and operational expansion of Revolution Medicines in Poland, including P&L management and the development of pre-launch and commercialization plans. Build and lead a high-performing country team while ensuring compliance with local regulations and internal policies.
Lead the definition and execution of the economic modeling strategy to produce high-quality health economic models across the company's oncology portfolio. This includes overseeing HTA submissions, payer evidence generation, and the integration of evolving HTA guidelines.
The MSL will cultivate professional relationships with Key Opinion Leaders and healthcare providers in Japan to support the company's oncology pipeline. They will provide scientific expertise to internal teams and support medical education, advisory boards, and clinical study sites.
Lead engagement with Lung Cancer Key Opinion Leaders in the Central Rockies to inform brand strategy and execute commercial tactics. Collaborate cross-functionally to support the US launch of RAS(ON) inhibitors and communicate market insights to the organization.
The Director, MSL will cultivate relationships with key opinion leaders and healthcare providers to advance scientific knowledge of RAS-addicted cancers. They will serve as a therapeutic expert, providing scientific support for medical congresses, advisory boards, and internal cross-functional teams.
The Director will develop and execute regional CMC regulatory strategies to support clinical development, marketing authorizations, and lifecycle management in Europe. They will serve as the primary lead for interactions with the EMA and national competent authorities while providing strategic guidance across cross-functional teams.
